JPY7,367.00
1.78% yesterday
Tokyo, Jul 25, 08:15 am CET
ISIN
JP3519400000
Symbol
4519
Index

Chugai Pharmaceutical Target price 2025 - Analyst rating & recommendation

Chugai Pharmaceutical Classifications & Recommendation:

Buy
60%
Hold
40%

Chugai Pharmaceutical Price Target

Target Price JPY8,874.00
Price JPY7,341.00
Potential
Number of Estimates 16
16 Analysts have issued a price target Chugai Pharmaceutical 2026 . The average Chugai Pharmaceutical target price is JPY8,874.00. This is higher than the current stock price. The highest price target is
JPY12,600.00 71.64%
register free of charge
, the lowest is
JPY6,363.00 13.32%
register free of charge
.
A rating was issued by 20 analysts: 12 Analysts recommend Chugai Pharmaceutical to buy, 8 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Chugai Pharmaceutical stock has an average upside potential 2026 of . Most analysts recommend the Chugai Pharmaceutical stock at Purchase.

Sales and Margin forecast 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Billion JPY 1,170.61 1,230.73
5.33% 5.14%
EBITDA Margin 46.87% 51.00%
16.70% 8.82%
Net Margin 33.09% 34.95%
12.98% 5.63%

19 Analysts have issued a sales forecast Chugai Pharmaceutical 2025 . The average Chugai Pharmaceutical sales estimate is

JPY1.2t
Unlock
. This is
0.70% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
JPY1.3t 8.34%
Unlock
, the lowest is
JPY1.2t 4.96%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 JPY1.2t 5.33%
2025
JPY1.2t 5.14%
Unlock
2026
JPY1.3t 3.45%
Unlock
2027
JPY1.3t 4.86%
Unlock

19 Chugai Pharmaceutical Analysts have issued a net profit forecast 2025. The average Chugai Pharmaceutical net profit estimate is

JPY430b
Unlock
. This is
4.87% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
JPY474b 15.58%
Unlock
, the lowest is
JPY366b 10.69%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 JPY387b 19.00%
2025
JPY430b 11.05%
Unlock
2026
JPY458b 6.57%
Unlock
2027
JPY488b 6.44%
Unlock

Net Margin

2024 33.09% 12.98%
2025
34.95% 5.63%
Unlock
2026
36.00% 3.00%
Unlock
2027
36.54% 1.50%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share JPY 235.36 261.31
18.99% 11.03%
P/E 27.70
EV/Sales 8.74

19 Analysts have issued a Chugai Pharmaceutical forecast for earnings per share. The average Chugai Pharmaceutical EPS is

JPY261.31
Unlock
. This is
4.85% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
JPY287.99 15.55%
Unlock
, the lowest is
JPY222.54 10.71%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 JPY235.36 18.99%
2025
JPY261.31 11.03%
Unlock
2026
JPY278.47 6.57%
Unlock
2027
JPY296.41 6.44%
Unlock

P/E ratio

Current 29.04 6.20%
2025
27.70 4.62%
Unlock
2026
25.99 6.17%
Unlock
2027
24.42 6.04%
Unlock

Based on analysts' sales estimates for 2025, the Chugai Pharmaceutical stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 8.80 5.01%
2025
8.74 0.67%
Unlock
2026
8.45 3.34%
Unlock
2027
8.06 4.64%
Unlock

P/S ratio

Current 9.58 4.83%
2025
9.51 0.70%
Unlock
2026
9.19 3.34%
Unlock
2027
8.76 4.64%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today